Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588939 · ClinicalTrials.gov registry record
Confocal Laser Microscopy in Non Erosive Reflux Disease
A clinical trial of Heartburn and Acid Reflux Disease, sponsored by Mayo Clinic.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT00588939: Completed study of Heartburn and Acid Reflux Disease, sponsored by Mayo Clinic.
NCT00588939 is a study of Heartburn and Acid Reflux Disease that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 413-participant average among 9 other Heartburn trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00588939, a study of Heartburn and Acid Reflux Disease, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Heartburn or reflux disease affects about 20% of Americans. 50 - 70% of people who have endoscopy for reflux disease have a normal appearing esophagus. Confocal Laser Microscopy allows us to see changes in the cells not visable during routine endoscopy. Whe goal of this study is to identify the use of this new technique in diagnosing reflux in patients who have normal appearing esophagus.
Conditions Studied
Interventions
- DEVICE Cell~vizio (Laser connfocal microscopy)
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-11 |
| Est. Completion | 2012-12 |
What the finished NCT00588939 record still lists
NCT00588939 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 413-participant average among 9 other Heartburn trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Heartburn appearing as the primary indexed condition, and to 1 intervention - of which Cell~vizio (Laser connfocal microscopy) is the first listed.
NCT00588939 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00588939 about?
NCT00588939 is a clinical study titled "Confocal Laser Microscopy in Non Erosive Reflux Disease". Heartburn or reflux disease affects about 20% of Americans. 50 - 70% of people who have endoscopy for reflux disease have a normal appearing esophagus. Confocal Laser Microscopy allows us to see changes in the cells not visable during routine endoscopy. Whe goal of this study is to identify the use ...
What is the current status of trial NCT00588939?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2008-11. Estimated completion is 2012-12.
What conditions does trial NCT00588939 study?
This clinical trial studies the following conditions: Heartburn, Acid Reflux Disease.
What interventions are being tested in trial NCT00588939?
The interventions under investigation include: Cell~vizio (Laser connfocal microscopy) (DEVICE).
Who is sponsoring clinical trial NCT00588939?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00588939 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heartburn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00588939's enrollment target sits among peer trials
60 8th of 9 higher than 2 of 9 other Heartburn trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heartburn trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
RECRUITING · NA
-
Domperidone in Treating Patients With Gastrointestinal Disorders
RECRUITING · Phase 3
-
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
RECRUITING
-
Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
COMPLETED · Phase 3
-
E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
COMPLETED · Phase 3
-
E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia